MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gurevich, V. V.
Right arrow Articles by Benovic, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gurevich, V. V.
Right arrow Articles by Benovic, J. L.

0026-895X/97/010161-09$3.00/0
Copyright © by The American Society for Pharmacology and Experimental Therapeutics
All rights of reproduction in any form reserved.
MOLECULAR PHARMACOLOGY 51:161-169 (1997).

Mechanism of Phosphorylation-Recognition by Visual Arrestin and the Transition of Arrestin into a High Affinity Binding State

Vsevolod V. Gurevich1 and Jeffrey L. Benovic

Department of Biochemistry and Molecular Pharmacology, Kimmel Cancer Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107

Arrestin plays an important role in quenching phototransduction via its ability to interact specifically with the phosphorylated light-activated form of the visual receptor rhodopsin (P-Rh*). Previous studies have demonstrated that Arg175 in bovine arrestin is directly involved in the phosphorylation-dependent binding of arrestin to rhodopsin and seems to function as a phosphorylation-sensitive trigger. In this study, we further probed the molecular mechanism of phosphorylation recognition by substituting 19 different amino acids for Arg175. We also assessed the effects of mutagenesis of several other highly conserved residues within the phosphorylation-recognition region (Val170, Leu172, Leu173, Ile174, Val177, and Gln178). The binding of all of these mutants to P-Rh*, light-activated rhodopsin, and truncated rhodopsin, which lacks the carboxyl-terminal phosphorylation sites, was then characterized. Overall, our results suggest that arrestin interaction with the phosphorylated carboxyl-terminal domain of rhodopsin activates two relatively independent changes in arrestin: (a) mobilization of additional binding sites and (b) increased affinity of the phosphorylation-recognition region for the rhodopsin carboxyl-terminal domain. Together, these two mechanisms ensure the exquisite selectivity of arrestin toward P-Rh*. Mutagenesis of residues that play a major role in binding site mobilization and phosphorylation-recognition enabled us to create "constitutively active" (phosphorylation-independent) arrestin mutants that have high affinity for both P-Rh* and light-activated rhodopsin. The introduction of a negative charge in position 175 was particularly effective in this respect. A detailed molecular model of phosphorylation-recognition is proposed.


Copyright © by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. A. Vishnivetskiy, D. Raman, J. Wei, M. J. Kennedy, J. B. Hurley, and V. V. Gurevich
Regulation of Arrestin Binding by Rhodopsin Phosphorylation Level
J. Biol. Chem., November 2, 2007; 282(44): 32075 - 32083.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. N. Nobles, Z. Guan, K. Xiao, T. G. Oas, and R. J. Lefkowitz
The Active Conformation of beta-Arrestin1: DIRECT EVIDENCE FOR THE PHOSPHATE SENSOR IN THE N-DOMAIN AND CONFORMATIONAL DIFFERENCES IN THE ACTIVE STATES OF beta-ARRESTINS1 AND -2
J. Biol. Chem., July 20, 2007; 282(29): 21370 - 21381.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. Mashukova, M. Spehr, H. Hatt, and E. M. Neuhaus
beta-Arrestin2-Mediated Internalization of Mammalian Odorant Receptors
J. Neurosci., September 27, 2006; 26(39): 9902 - 9912.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
N. Wu, R. Macion-Dazard, S. Nithianantham, Z. Xu, S. M. Hanson, S. A. Vishnivetskiy, V. V. Gurevich, M. Thibonnier, and M. Shoham
Soluble Mimics of the Cytoplasmic Face of the Human V1-Vascular Vasopressin Receptor Bind Arrestin2 and Calmodulin
Mol. Pharmacol., July 1, 2006; 70(1): 249 - 258.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. M. Hanson, D. J. Francis, S. A. Vishnivetskiy, E. A. Kolobova, W. L. Hubbell, C. S. Klug, and V. V. Gurevich
Differential interaction of spin-labeled arrestin with inactive and active phosphorhodopsin
PNAS, March 28, 2006; 103(13): 4900 - 4905.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. J. Vaughan, E. E. Millman, V. Godines, J. Friedman, T. M. Tran, W. Dai, B. J. Knoll, R. B. Clark, and R. H. Moore
Role of the G Protein-coupled Receptor Kinase Site Serine Cluster in beta2-Adrenergic Receptor Internalization, Desensitization, and beta-Arrestin Translocation
J. Biol. Chem., March 17, 2006; 281(11): 7684 - 7692.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. M. Hanson and V. V. Gurevich
The Differential Engagement of Arrestin Surface Charges by the Various Functional Forms of the Receptor
J. Biol. Chem., February 10, 2006; 281(6): 3458 - 3462.
[Abstract] [Full Text] [PDF]


Home page
J Biomol ScreenHome page
M. Vrecl, R. Jorgensen, A. Pogacnik, and A. Heding
Development of a BRET2 Screening Assay Using {beta}-Arrestin 2 Mutants
J Biomol Screen, June 1, 2004; 9(4): 322 - 333.
[Abstract] [PDF]


Home page
Mol. Pharmacol.Home page
J. A. Gray, A. Bhatnagar, V. V. Gurevich, and B. L. Roth
The Interaction of a Constitutively Active Arrestin with the Arrestin-Insensitive 5-HT2A Receptor Induces Agonist-Independent Internalization
Mol. Pharmacol., May 1, 2003; 63(5): 961 - 972.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. A. Vishnivetskiy, J. A. Hirsch, M.-G. Velez, Y. V. Gurevich, and V. V. Gurevich
Transition of Arrestin into the Active Receptor-binding State Requires an Extended Interdomain Hinge
J. Biol. Chem., November 8, 2002; 277(46): 43961 - 43967.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Mukherjee, V. V. Gurevich, A. Preninger, H. E. Hamm, M.-F. Bader, A. T. Fazleabas, L. Birnbaumer, and M. Hunzicker-Dunn
Aspartic Acid 564 in the Third Cytoplasmic Loop of the Luteinizing Hormone/Choriogonadotropin Receptor Is Crucial for Phosphorylation-independent Interaction with Arrestin2
J. Biol. Chem., May 10, 2002; 277(20): 17916 - 17927.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Dinculescu, J. H. McDowell, S. A. Amici, D. R. Dugger, N. Richards, P. A. Hargrave, and W. C. Smith
Insertional Mutagenesis and Immunochemical Analysis of Visual Arrestin Interaction with Rhodopsin
J. Biol. Chem., March 29, 2002; 277(14): 11703 - 11708.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. M. Potter, T. A. Key, V. V. Gurevich, L. A. Sklar, and E. R. Prossnitz
Arrestin Variants Display Differential Binding Characteristics for the Phosphorylated N-Formyl Peptide Receptor Carboxyl Terminus
J. Biol. Chem., March 8, 2002; 277(11): 8970 - 8978.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
W. C. Smith, E. V. Gurevich, D. R. Dugger, S. A. Vishnivetskiy, C. L. Shelamer, J. H. McDowell, and V. V. Gurevich
Cloning and Functional Characterization of Salamander Rod and Cone Arrestins
Invest. Ophthalmol. Vis. Sci., August 1, 2000; 41(9): 2445 - 2455.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
K. B. Lee, J. A. Ptasienski, R. Pals-Rylaarsdam, V. V. Gurevich, and M. M. Hosey
Arrestin Binding to the M2 Muscarinic Acetylcholine Receptor Is Precluded by an Inhibitory Element in the Third Intracellular Loop of the Receptor
J. Biol. Chem., March 24, 2000; 275(13): 9284 - 9289.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Schubert, J. A. Hirsch, V. V. Gurevich, D. M. Engelman, P. B. Sigler, and K. G. Fleming
Visual Arrestin Activity May Be Regulated by Self-association
J. Biol. Chem., July 23, 1999; 274(30): 21186 - 21190.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. A. Vishnivetskiy, C. L. Paz, C. Schubert, J. A. Hirsch, P. B. Sigler, and V. V. Gurevich
How Does Arrestin Respond to the Phosphorylated State of Rhodopsin?
J. Biol. Chem., April 23, 1999; 274(17): 11451 - 11454.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Mukherjee, K. Palczewski, V. Gurevich, J. L. Benovic, J. P. Banga, and M. Hunzicker-Dunn
A direct role for arrestins in desensitization of the luteinizing hormone/choriogonadotropin receptor in porcine ovarian follicular membranes
PNAS, January 19, 1999; 96(2): 493 - 498.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. J. Orsini and J. L. Benovic
Characterization of Dominant Negative Arrestins That Inhibit beta 2-Adrenergic Receptor Internalization by Distinct Mechanisms
J. Biol. Chem., December 18, 1998; 273(51): 34616 - 34622.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. V. Gurevich
The Selectivity of Visual Arrestin for Light-activated Phosphorhodopsin Is Controlled by Multiple Nonredundant Mechanisms
J. Biol. Chem., June 19, 1998; 273(25): 15501 - 15506.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. V. Gurevich, R. Pals-Rylaarsdam, J. L. Benovic, M. M. Hosey, and J. J. Onorato
Agonist-Receptor-Arrestin, an Alternative Ternary Complex with High Agonist Affinity
J. Biol. Chem., November 14, 1997; 272(46): 28849 - 28852.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. G. Krupnick, V. V. Gurevich, and J. L. Benovic
Mechanism of Quenching of Phototransduction. BINDING COMPETITION BETWEEN ARRESTIN AND TRANSDUCIN FOR PHOSPHORHODOPSIN
J. Biol. Chem., July 18, 1997; 272(29): 18125 - 18131.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. B. Lee, J. A. Ptasienski, M. Bunemann, and M. M. Hosey
Acidic Amino Acids Flanking Phosphorylation Sites in the M2 Muscarinic Receptor Regulate Receptor Phosphorylation, Internalization, and Interaction with Arrestins
J. Biol. Chem., November 10, 2000; 275(46): 35767 - 35777.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Pulvermuller, K. Schroder, T. Fischer, and K. P. Hofmann
Interactions of Metarhodopsin II. ARRESTIN PEPTIDES COMPETE WITH ARRESTIN AND TRANSDUCIN
J. Biol. Chem., November 22, 2000; 275(48): 37679 - 37685.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. A. Vishnivetskiy, C. Schubert, G. C. Climaco, Y. V. Gurevich, M.-G. Velez, and V. V. Gurevich
An Additional Phosphate-binding Element in Arrestin Molecule. IMPLICATIONS FOR THE MECHANISM OF ARRESTIN ACTIVATION
J. Biol. Chem., December 22, 2000; 275(52): 41049 - 41057.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
U. Klein, C. Muller, P. Chu, M. Birnbaumer, and M. von Zastrow
Heterologous Inhibition of G Protein-coupled Receptor Endocytosis Mediated by Receptor-specific Trafficking of beta -Arrestins
J. Biol. Chem., May 11, 2001; 276(20): 17442 - 17447.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Celver, S. A. Vishnivetskiy, C. Chavkin, and V. V. Gurevich
Conservation of the Phosphate-sensitive Elements in the Arrestin Family of Proteins
J. Biol. Chem., March 8, 2002; 277(11): 9043 - 9048.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Shiina, A. Kawasaki, T. Nagao, and H. Kurose
Interaction with beta -Arrestin Determines the Difference in Internalization Behavior between beta 1- and beta 2-Adrenergic Receptors
J. Biol. Chem., September 8, 2000; 275(37): 29082 - 29090.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics